reports
- Olfa Taamallah
- Yan Derocles
VLS VALNEVA SE
ELG ELMOS SEMICONDUCTOR SE
NOEJ NORMA GROUP SE
ELIS ELIS SA
SHA SCHAEFFLER AG
KRN KRONES AG
PSPN PSP SWISS PROPERTY AG
SIGHT GENSIGHT BIOLOGICS SA
BEZ BERENTZEN GRUPPE
ASS APPLUS SERVICES S.A.
COFA COFACE SA
JUN3 JUNGHEINRICH AG PREF
IDR INDRA SISTEMAS S.A. CLASS A
TMV TEAMVIEWER AG
HAG HENSOLDT AG
- ABGSC Credit Research
- Bendik Fougner Engebretsen
- Carole Braudeau
Morning Crédit 07/05/2024
Monte publie un T1 2024 solide, au-dessus des attentesZalando : objectifs confirmés à l’issue d’un T1 supérieur aux attentes, envisage des rachats d’obligations convertibles 2025 pour 100 m EUR maximumClariane a reçu une offre pour la cession de ses activités HAD/SSIAD en FranceBanco Sabadell rejette la proposition de fusion de BBVA>...
- Martin Marandon-Carlhian
- Stephane Houri
FME FRESENIUS MEDICAL CARE AG & CO. KGAA
RCO REMY COINTREAU SA
LONN LONZA GROUP AG
EN BOUYGUES SA
ADEN ADECCO GROUP AG
SCR SCOR SE
ZAL ZALANDO SE
GEBN GEBERIT AG
HEI HEIDELBERGCEMENT AG
SOLB SOLVAY SA
COLO B COLOPLAST A/S CLASS B
BP. BP P.L.C.
SHL SIEMENS HEALTHINEERS AG
UN0 UNIPER SE
- ABGSC IT Research
- Øystein Elton Lodgaard
Air Liquide : MODIFICATION DE CAPITAL
PARIS--(BUSINESS WIRE)-- Regulatory News: Air Liquide (Paris:AI) : Réduction de capital par annulation d’actions Faisant usage de l’autorisation donnée par l’Assemblée Générale Mixte du 3 Mai 2023 en sa 18ème résolution, le Conseil d’Administration dans sa séance du 30 avril 2024 a décidé de réduire le capital social d’un montant de 3 448 500 euros pour le ramener de 2 884 842 279,00 euros à 2 881 393 779,00 euros par annulation de 627 000 (six cent vingt sept mille) actions acquises en vertu de l’autorisation donnée par l’Assemblée Générale Ordinaire du 3 mai 2023 (dans sa 4ème résoluti...
Loihde Oyj: 1 director
A director at Loihde Oyj bought 2,500 shares at 13.945EUR and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Wihlborgs Fastigheter AB: 1 director
A director at Wihlborgs Fastigheter AB sold 8,000 shares at 94.200SEK and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
Timken Co: 2 directors
Two Directors at Timken Co sold/sold after exercising options 99,006 shares at between 88.860USD and 89.406USD. The significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the compa...
Scandi Standard AB: 4 directors
Two Directors at Scandi Standard AB bought 102,534 shares at between 72.250SEK and 72.560SEK. The significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...
- Emmanuel Matot
Arkema : No major surprises in the quarterly publication
>EBITDA down in Q1 but not by as much as expected - Arkema has just reported its Q1 2024 results. EBITDA was down 5% to € 350m, 3% above forecasts (ODDO BHF / consensus = € 340m/€ 341m) and 6% above the guidance (€ 331m corresponding to Q4 2023).The group continues to operate in a context of weak demand (volumes = 0%, of which +3% for speciality chemicals and -28% intermediates – as a reminder Q4 2023= +2%). By division, adhesives and advanced materials delivere...
- Olfa Taamallah
- Yan Derocles
VLS VALNEVA SE
ELG ELMOS SEMICONDUCTOR SE
NOEJ NORMA GROUP SE
ELIS ELIS SA
SHA SCHAEFFLER AG
KRN KRONES AG
PSPN PSP SWISS PROPERTY AG
SIGHT GENSIGHT BIOLOGICS SA
BEZ BERENTZEN GRUPPE
ASS APPLUS SERVICES S.A.
COFA COFACE SA
JUN3 JUNGHEINRICH AG PREF
IDR INDRA SISTEMAS S.A. CLASS A
TMV TEAMVIEWER AG
HAG HENSOLDT AG
EQS-News: Health-Tech-Stars 2024: Das ist die Shortlist für den Digita...
EQS-News: Novartis Pharma GmbH / Schlagwort(e): Sonstiges Health-Tech-Stars 2024: Das ist die Shortlist für den Digitalen Gesundheitspreis von Novartis 07.05.2024 / 10:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Health-Tech-Stars 2024: Das ist die Shortlist für den Digitalen Gesundheitspreis von Novartis Aus mehr als 90 Bewerbungen hat die unabhängige, ehrenamtliche Jury des Digitalen Gesundheitspreises die besten fünf Projekte zu den Schwerpunktthemen #Sekundärprävention, #DigitaleTherapiewege und #FortschrittDurchDaten ausgew...
Li Auto Inc. to Report First Quarter 2024 Financial Results on May 20,...
Li Auto Inc. to Report First Quarter 2024 Financial Results on May 20, 2024 BEIJING, China, May 07, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it will report its unaudited financial results for the first quarter of 2024 before the U.S. market opens on Monday, May 20, 2024. The Company’s management will hold an earnings conference call on Monday, May 20, 2024, at 8:00 A.M. U.S. Eastern Time or 8:00 P.M. Beijing/Hong Kong Time on the same day. For participants who ...
- Geoffroy Michalet
Applus Service SA : Applus story set to come to a close soon... Target...
>No Q1 revenues - The group did not report its Q1 revenues due to the ongoing public tender offer. We had a contact with the company and noted that top-line momentum remains strong in the high single digits, carrying on from Q4 2023. Where the takeover bid is concerned, on 30 April 2024, the CNMV confirmed that Amber’s winning bid (TDR & I Squared) is the successful offer and will be subject to an acceptation period. Last Friday, the two funds filed their propos...
- ABGSC Financials Research
- Fredrik Flørnes Støle
- Jan Erik Gjerland
- Research Department
- Martin Marandon-Carlhian
- Stephane Houri
INFINEON INFINEON TECHNOLOGIES AG
FME FRESENIUS MEDICAL CARE AG & CO. KGAA
RCO REMY COINTREAU SA
LONN LONZA GROUP AG
EN BOUYGUES SA
ADEN ADECCO GROUP AG
SCR SCOR SE
ZAL ZALANDO SE
GEBN GEBERIT AG
HEI HEIDELBERGCEMENT AG
SOLB SOLVAY SA
COLO B COLOPLAST A/S CLASS B
BP. BP P.L.C.
SHL SIEMENS HEALTHINEERS AG
UN0 UNIPER SE
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.